Navarro; Eva Figueroa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Navarro; Eva Figueroa.The latest application filed is for "hydroxybenzamide derivatives and their use as inhibitors of hsp90".

Company Profile

0.13.20

Navarro; Eva Figueroa - Cambridge GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Hydroxybenzamide derivatives and their use as inhibitors of HSP90 Grant 9,914,719 - Chessari , et al. March 13, 2	2018-03-13
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 App 20150045362 - Chessari; Gianni ; et al.	2015-02-12
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 Grant 8,816,087 - Chessari , et al. August 26, 2	2014-08-26
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases Grant 8,778,936 - Berdini , et al. July 15, 2	2014-07-15
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors App 20140010892 - BERDINI; Valerio ; et al.	2014-01-09
Therapeutic combinations of hydroxybenzamide derivatives as inhibitors of HSP90 Grant 8,530,469 - Chessari , et al. September 10, 2	2013-09-10
Pyrazole Compounds That Modulate The Activity Of Cdk, Gsk And Aurora Kinases App 20120190673 - BERDINI; Valerio ; et al.	2012-07-26
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases Grant 8,110,573 - Berdini , et al. February 7, 2	2012-02-07
Dihydroxyphenyl isoindolylmethanones Grant 8,106,057 - Chessari , et al. January 31, 2	2012-01-31
Hydroxybenzamide derivatives and their use as inhibitors of HSP90 Grant 8,101,648 - Chessari , et al. January 24, 2	2012-01-24
Benzimidazole Derivatives And Their Use As Protein Kinase Inhibitors App 20110224203 - BERDINI; Valerio ; et al.	2011-09-15
Benzimidazole derivatives and their use as protein kinase inhibitors Grant 7,977,477 - Berdini , et al. July 12, 2	2011-07-12
Dihydroxyphenyl Isoindolylmethanones App 20100286167 - Chessari; Gianni ; et al.	2010-11-11
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of Hsp90 App 20100216782 - CHESSARI; Gianni ; et al.	2010-08-26
Dihydroxyphenyl isoindolymethanones Grant 7,754,725 - Chessari , et al. July 13, 2	2010-07-13
Pyrazole Derivatives As That Modulate The Activity Of Cdk, Gsk And Aurora Kinases App 20100160324 - Berdini; Valerio ; et al.	2010-06-24
Hydroxybenzamide derivatives and their use as inhibitors of Hsp90 Grant 7,700,625 - Chessari , et al. April 20, 2	2010-04-20
4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer App 20090318500 - Trewartha; Gary ; et al.	2009-12-24
Hydroxybenzamide derivatives and their use as inhibitors of HSP90 App 20090215772 - Chessari; Gianni ; et al.	2009-08-27
Pharmaceutical Compounds App 20080306054 - Chessari; Gianni ; et al.	2008-12-11
Pyrazole Derivatives for the Inhibition of CDK'S and GSK'S App 20080306069 - Wyatt; Paul Graham ; et al.	2008-12-11
Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's App 20080194562 - Wyatt; Paul Graham ; et al.	2008-08-14
Pyrazole Compounds that Modulate the Activity of Cdk, Gsk and Aurora Kinases App 20080132495 - Berdini; Valerio ; et al.	2008-06-05
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 App 20070276026 - Chessari; Gianni ; et al.	2007-11-29
Dihydroxyphenyl Isoindolylmethanones App 20070259886 - Chessari; Gianni ; et al.	2007-11-08
Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90 App 20070259871 - Chessari; Gianni ; et al.	2007-11-08
Benzimidazole derivatives and their use as protein kinases inhibitors App 20070135477 - Berdini; Valerio ; et al.	2007-06-14
Pharmaceutical compounds App 20070105900 - Berdini; Valerio ; et al.	2007-05-10
Chk-1 inhibitors App 20060035920 - Boyle; Robert George ; et al.	2006-02-16
Chk-1 inhibitors App 20050245563 - Boyle, Robert George ; et al.	2005-11-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.